Mark Glickman work email
- Valid
- Valid
- Valid
- Valid
- Valid
Mark Glickman personal email
- Valid
- Valid
- Valid
Mark Glickman phone numbers
Throughout the past 30+ years, I have excelled in building organizations, transitioning clinical companies into commercial, launching 13 new products, negotiating and closing major licensing deals, negotiating mergers and acquisitions, reconfiguring infrastructures, integrating acquired companies, and generating significant revenue and profit gains, all leading to significant value for shareholders. Over the past several years, I have established two new commercial entities and successfully launched 3 products, 1 directly into the global pandemic, generating significant revenue in 2020. Additionally in 2019, I negotiated and closed the two largest out-license deals in pharmaceutical history. A 900 million dollar, EU deal with 300 million up front and a 510 million dollar Japan deal with 60 million up front.These two deals provided the short term cash to support the new commercial initiatives with no additional capital raisesIn senior executive roles, I transformed new entities, or underperforming, inefficient, and declining operations into high-achieving companies. By spearheading innovative product launches, including orphan launches, directing quality improvements, and ensuring FDA/regulatory compliance, I have led established organizations to up to 700% revenue growth, creating billions of dollars in recognized shareholder premiums. My successes resulted from my ability to oversee the entirety of P&L activities, from introducing new products and achieving far greater than forecasted outcomes to returning failing products to profitability and expanding sales opportunities to innovative channels and opening up international markets. As a visionary leader, I possess a unique blend of financial skills and commercial experience, with expertise that ranges from development of early-stage companies to expansion of well-established organizations.I am particularly adept at setting up and building commercial and service organizations, building the distribution and order to cash process, , conceiving brand awareness campaigns, leading target market research efforts, formulating thorough launch plans. In leadership roles, I created value through Business development and licensing, Mergers and acquisitions and significant revenue growth.
-
President And Chief Executive OfficerBioflorida, Inc. Dec 2023 - PresentBoynton Beach, Florida, Us -
Member Board Of DirectorsNeurobo Pharmaceuticals, Inc. May 2023 - PresentBoston, Massachusetts, UsCurrently sit on Audit and Compensation Committee -
Member Board Of DirectorsOtsuka Precision Health, Inc. (Oph) May 2024 - PresentPrinceton , New Jersey, Us -
Chief Business OfficerTherapeuticsmd Jun 2021 - May 2023Boca Raton, Florida, Us -
Co-Chief Executive Officer And Chief Business Officer (Sold To Mayne Pharma 1/2023)Therapeuticsmd Sep 2022 - Feb 2023Boca Raton, Florida, Us
-
Chief Commercial OfficerEsperion - The Lipid Management Company Apr 2018 - Dec 2020Ann Arbor, Michigan, UsRecruited by CEO to transition Esperion, A company focused on Cardiovascular disease, from a research-based company into a fully operational, global, commercial organization .The goal was to build a global commercial entity that will lead to a successful launch of a phase 3, small molecule cardiovascular therapy. Areas of focus are on business development and licensing, global distribution options, building the order to cash process, and ultimately to build the various commercial teams.Established a successful process that lead to the signing of 2 precedent setting deals, avoiding the need for acquiring additional capital to fund the new, commercial, phase of Esperiono The largest European licensing deal in the pharmaceutical industry. The deal was 900 million dollars total, 300 million in upfront cash, plus royalties o The largest license deal in Japan 510 Million total, 60 million up front plus royalties -
Chief Commercial OfficerAralez Pharmaceuticals Inc. Jun 2015 - Apr 2018Mississauga, Ontario, CaRecruited by CEO to transform a research-based company into a fully operational, public, commercial organization. To date, I successfully built the Commercial, Analytical, Distribution and Trade infrastructure and created a fully functional, integrated commercial entity. -
Executive Vice President, Sales And Marketing (Acquired By Endo Pharmaceuticals)Auxilium Pharmaceuticals Feb 2012 - Mar 2015UsAs a respected and highly effective sales executive, I was recruited by the CEO of Auxilium for this Chief Marketing & Sales Officer role. Charged with rebuilding the entire revenue-generation and product-support organization, I created the infrastructure necessary to acquire new companies, successfully launch innovative products, and increase shareholder value. During my tenure, I lead a commercial group of 410 pharmaceutical professionals, including 335 in sales, 35 in marketing, and 35+ in managed market and field reimbursement.Highlights included:* Company acquired for a 70% premium representing a 3x increase in market cap during my three year tenure* Seamlessly incorporated a 200-person specialty pharmaceutical company, boosting sales and recognizing significant synergy savings.* Successfully introduced 2 new products, including a specialty orphan disease biotech. Licensed and launched a PDE5 for erectile dysfunction.* Built a first-in-class hub model to ensure physicians and patients had access to a highly priced specialty biopharmaceutical.* Offered high-touch, value-added service, encompassing benefit investigation through to possible appeal process. Service enabled > 90% of patients to receive treatment (twice the original goal).* In 2 years, increased income 100%, generating Auxilium’s first positive earnings in the company’s 12-year history. -
Vice President-Medical Device DivisionOtsuka America Pharmaceutical, Inc. Feb 2009 - Feb 2012Princeton, Nj, UsI joined OAPI as a key member of the executive team and rapidly facilitated reorganization and reinvigoration of a troubled MDD division, reversing a history of declining sales, production problems, and regulatory issues. In aligning MDD with OAPI’s strategic vision, I stabilized the division, reduced costs and risks, and promoted growth and development, through oversight of international distribution, marketing, systems physician and national lab sales, customer and technical services, contracting, R&D, and quality.Highlights included:* Increased business 50% during 2 years versus 4% decline in year prior to arrival.* Strategically re-launched a product with improvements in value proposition, reimbursement expectations, and CPT code management.* Spearheaded creation of new system that enabled successful closeout of existing FDA 483, resulting in significant cost savings.* Established company’s first customer call center, handling 600+ monthly inquiries and improving customer service metrics.* Led team in submitting a new PMA and acquiring an additional development candidate already in phase II. Worked on a pre-launch IM depot injection. -
Senior Vice President Sales And MarketingOscient Pharmaceuticals Aug 2007 - Feb 2009UsBased on my successes with Kos, BMS, and Baxter, the CEO of Oscient recruited me to build a new executive team and execute an aggressive turnaround strategy after the company had exited a co-promotion relationship. I directed P&L of the US commercial organization, including physician, wholesale, and retail sales, managed care sales and contracting, and sales training. Within 2 years, I restructured the entire group while exceeding corporate financial goals for a commercial organization consisting of 350 employees, including a 300-member sales team. I immediately created an assessment process that identified weak performers, motivated high-potential staff, and hired 100+ quality employees, including 6 directors in sales, managed care, and sales operations.Highlights included:* Rapidly added incremental revenue to cardiovascular and antibiotic franchise, increasing shareholder value which had declined 99% during the previous 4 years.* Increased sales by more than 50% in first 6 months with 28% annual growth rate. -
Vp Sales (Acquired By Abbott Labs)Kos Pharmaceuticals May 2001 - Feb 2007UsAfter leading my district to #1 national ranking and nearly doubling revenues at BMS, I was recruited by the VP of Sales and Marketing at Kos to launch Advicor, the flagship company brand. As in the past, I quickly advanced into positions of increasing accountability and influence. I began as Director of Marketing (2001 – 2003), where I launched and marketed their first product in only 8 months, exceeding the first-year target by $25M. Then, I introduced the company’s second product, establishing a new class of therapy in the cardiovascular market with sales significantly better than 7 other launches by much-larger firms.The CEO handpicked me to turn around the perpetually underperforming Eastern Region, with oversight of 10 district managers and 120 territory managers. As Regional Sales Director (2003 – 2005), I reversed a region that had been stagnant from 1997, by improving market share, increasing revenues, and elevating bottom-line profitability. Next, I was promoted to National Vice President of Sales and Sales Operations (2005 – 2007) and charged with building the company through organic growth and acquisition. I rapidly achieved synergy and revenue goals for the acquired company and exceeded forecasted goals with only one-third of the original assets in place.Highlights included:* Expanded sales and operations group from approximately 400 to nearly 600 personnel, and more than tripled annual revenues.* Led reorganized and revitalized field sales team to 30% positive sales growth after declining by nearly one-third during previous 3 years.* Led Eastern Region from last in performance to the #1 position in the company within a 10-month period.* Reduced voluntary turnover from 26% to 0%, savings millions of dollars in recruiting and training expenses.* Created highly successful sales aids and journal ads that resulted in 98% product remembrance rate, the highest rate ever recorded for any brand previously tested by Barnes & Hollander. -
Senior Product ManagerBristol-Myers Squibb 1997 - 2001Lawrence Township, Nj, UsIn less than 4 years with Bristol-Myers Squibb, I earned rapid promotions from Hospital and Specialty Senior District Business Manager (1998) to Product Manager CV Vanlev (1998 – 2000) and then Senior Product Manager CV Plavix (2000 – 2001). During this period, I directed a wide range of sales and marketing initiatives, including product positioning, web marketing, brand launch, and a global marketing program. I identified and mentored sales reps and managers to #1 rankings, managed a joint venture marketing program that generated billions of dollars in revenues, and developed and implemented an Internet strategy for a new class of antihypertensive.Highlights included:* Led global launch, promotion, and education for highly regarded CURE trial which increased medical prescriptions by 50%.* Nearly doubled annual revenues through innovative promotional campaigns and sales strategies.* Introduced important data for a global congress, boosting sales after 2 flat quarters and setting redirection for future data launches.* Led opinion leader initiative that resulted in a change in AHA/ACC guidelines for Acute Coronary Syndrome, and successfully added Plavix as standard therapy under these new national guidelines.* Achieved highest prelaunch brand recognition ever achieved in the pharmaceutical industry at that time.* Completed first year with company as the top-performing DBM in the Northeast, elevating district to #1 from last place out of 8 districts. -
VariousBaxter Healthcare Jan 1989 - Dec 1995Deerfield, Illinois, UsGeneral Manager Hospital SalesDeerfield, IL1990 – 1995After joining Baxter in 1990, I quickly advanced from Sales Specialist (1990 – 1991) into sales leadership roles. First as Regional Sales Manager (1991 – 1994) and then as General Manager of Hospital Sales (1994 – 1995), I consistently exceeded sales targets and elevated sales rankings. Ultimately, I held accountability for a full range of products from linens to IV solutions, and leadership of 40 manufacturers’ and sales reps in marketing to all major hospitals in the New York and New Jersey area.
Mark Glickman Skills
Mark Glickman Education Details
-
Nyu Stern School Of BusinessFinance And International Management -
State University Of New York At OswegoBa
Frequently Asked Questions about Mark Glickman
What company does Mark Glickman work for?
Mark Glickman works for Bioflorida, Inc.
What is Mark Glickman's role at the current company?
Mark Glickman's current role is CEO | Board Member | Advisor.
What is Mark Glickman's email address?
Mark Glickman's email address is ma****@****-us.com
What is Mark Glickman's direct phone number?
Mark Glickman's direct phone number is 484-321*****
What schools did Mark Glickman attend?
Mark Glickman attended Nyu Stern School Of Business, State University Of New York At Oswego.
What skills is Mark Glickman known for?
Mark Glickman has skills like Leadership, Urology, Sales Force Development, Specialty Pharmaceutical, Nephrology, Selling Skills, Cardiology, Dermatology, Sales, Hypertension, Gastroenterology, Neurology.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial